Back to search
Rosacea, Erythematotelangiectatic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rosacea, Erythematotelangiectatic trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rosacea, Erythematotelangiectatic trials you may qualify forThere are 3 main objectives of this proposal as follows: (1) to assess the efficacy of radiofrequency microneedling in the treatment of erythematotelangiectatic…
The efficacy and safety of anti-inflammation treatment (Hirudoid introduction followed by yellow light therapy) combined with tofacitinib and doxycycline in Chi…
The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels assoc…
This study looks at whether a topical gel called 0.33% brimonidine can reduce persistent facial redness caused by rosacea. The study was carried out in two part…
Topical metronidazole is a widely used first line treatment for erythemotelangiectatic and inflammatory rosacea. Commonly, a moisturizer is also used to restore…